CATHEPSIN-D IN BREAST-CANCER

被引:104
|
作者
ROCHEFORT, H
机构
[1] Unité Hormones et Cancer (U 148) INSERM, University of Montpellier 1, Montpellier, 34090, 60, rue de Navacelles
关键词
estrogen; gene regulation; lysosomes; metastasis; prognostic marker; protease;
D O I
10.1007/BF01806570
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cathepsin D is an acidic lysosomal protease present in all cells. In estrogen receptor positive and negative breast cancer cell lines, the mRNA coding for pro-cathepsin D is overexpressed and sorting and maturation of the pro-enzyme are altered, leading to accumulation of the active proteinase in large endosomes and to secretion of the precursor (52K protein). In MCF7 cells, the cathepsin D mRNA is induced directly and transcriptionally by estrogens and indirectly by growth factors. In vitro, pro-cathepsin D is an autocrine mitogen on breast cancer cells and can be auto-activated to degrade extracellular matrix and proteoglycans and to activate other proteinases in acidic microenvironments. In patients, there is a significant correlation between high cathepsin D concentrations in the cytosol of primary breast cancer and development of metastasis. This marker is independent of other prognostic factors and appears to be particularly useful in lymph node-negative tumors. These results suggest that overexpression and possible derouting of cathepsin D plays an important role in invasion and metastasis of breast cancer. © 1990 Kluwer Academic Publishers.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 50 条
  • [31] Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors
    Jahkola, T
    Toivonen, T
    von Smitten, K
    Virtanen, I
    Wasenius, VM
    Blomqvist, C
    BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 167 - 174
  • [32] UBIQUITINATED INCLUSIONS IN INCLUSION-BODY MYOSITIS PATIENTS ARE IMMUNOREACTIVE FOR CATHEPSIN-D BUT NOT BETA-AMYLOID
    SHERRIFF, FE
    JOACHIM, CL
    SQUIER, MV
    ESIRI, MM
    NEUROSCIENCE LETTERS, 1995, 194 (1-2) : 37 - 40
  • [33] Release of the aspartyl protease cathepsin D is associated with and facilitates human breast cancer cell invasion
    Tedone, T
    Correale, M
    Barbarossa, G
    Casavola, V
    Paradiso, A
    Reshkin, SJ
    FASEB JOURNAL, 1997, 11 (10) : 785 - 792
  • [34] Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value
    Alhudiri, Inas
    Nolan, Christopher
    Ellis, Ian
    Elzagheid, Adam
    Green, Andrew
    Chapman, Caroline
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (01) : 143 - 153
  • [35] CHEST RADIOGRAPHY IN THE MANAGEMENT OF BREAST-CANCER
    MOSKOVIC, E
    PARSONS, C
    BAUM, M
    BRITISH JOURNAL OF RADIOLOGY, 1992, 65 (769) : 30 - 32
  • [36] DNA ANALYSIS IN ADVANCED BREAST-CANCER
    LEIVONEN, M
    KROGERUS, L
    NORDLING, S
    CANCER DETECTION AND PREVENTION, 1994, 18 (02): : 87 - 96
  • [37] INVASION AND METASTASIS FACTORS IN BREAST-CANCER
    BRUNNER, N
    DANO, K
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 24 (03) : 173 - 174
  • [38] ORGANOCHLORINE RESIDUES AND RISK OF BREAST-CANCER
    HOUGHTON, DL
    RITTER, L
    JOURNAL OF THE AMERICAN COLLEGE OF TOXICOLOGY, 1995, 14 (02): : 71 - 89
  • [39] Cathepsin D in cancer metastasis: A protease and a ligand
    Rochefort, H
    Liaudet-Coopman, E
    APMIS, 1999, 107 (01) : 86 - 95
  • [40] DIETHYLSTILBESTROL REVISITED IN ADVANCED BREAST-CANCER MANAGEMENT
    BOYER, MJ
    TATTERSALL, MHN
    MEDICAL AND PEDIATRIC ONCOLOGY, 1990, 18 (04): : 317 - 320